ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
23
views
0
references
Top references
cited by
220
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
1
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,947
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
Author(s):
H. Miyashita
,
T. Mikami
,
N. Chopra
,
T. Yamada
,
S. Chernyavsky
,
D. Rizk
,
C. Cruz
Publication date
Created:
August 2020
Publication date
(Print):
August 2020
Journal:
Annals of Oncology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Further versions
open (via crossref license)
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Novel Coronavirus Disease COVID-19
Author and article information
Journal
Title:
Annals of Oncology
Abbreviated Title:
Annals of Oncology
Publisher:
Elsevier BV
ISSN (Print):
09237534
Publication date Created:
August 2020
Publication date (Print):
August 2020
Volume
: 31
Issue
: 8
Pages
: 1088-1089
Article
DOI:
10.1016/j.annonc.2020.04.006
SO-VID:
06987304-ccfe-41f0-857b-d2df0bde5c3c
Copyright ©
© 2020
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,947
PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
Authors:
Yi-Teng Huang
,
Fei-fei Li
,
Chen-Yeh Ke
…
eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma
Authors:
Fangyingnan Zhang
,
Saquib Waheed
,
Ubaldo Armato
…
Re: A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank SpecimensDixon T. S. Woon, Jaime O. Herrera-Cáceres, Hanan Goldberg, Hina Shiakh, Emily Whelan, Gregory Nason, Khaled Ajib, Guan Hee Tan, Thenappan Chandrasekar, Omar Alhunaidi, Antonio Finelli, Alexandre Zlotta, Alejandro Berlin, Eleftherios Diamantis and Neil Fleshner J Urol 2020; 204: 289-295.
Authors:
Na Li
,
Yi Sun
,
Jin-Gui Li
…
See all similar
Cited by
213
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Authors:
Nicole M Kuderer
,
Toni K. Choueiri
,
Dimpy Shah
…
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Authors:
Lennard Y W Lee
,
Jean Cazier
,
T. Starkey
…
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Authors:
Lennard Y W Lee
,
Jean-Baptiste Cazier
,
Thomas Starkey
…
See all cited by
Version 1
Version 1
Version 1